A Study of LUT014 in Patients With Metastatic Colorectal Cancer With EGFR Inhibitor Induced Acneiform Lesions
Clinical trial NCT03876106 · COMPLETED
Trial details
- NCT number
- NCT03876106
- Sponsor
- Lutris Pharma Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-21
- Primary completion
- 2020-07-09
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.